Back
Speaker illustration

Mr Matthew Chung

Busan (Korea (Republic of))

Presentations

When will be appropriate time for P2Y12 inhibitors dose de-escalation?

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Coronary artery disease: pharmacotherapy

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources